
Clover Health Investments, Corp. (CLOV) Q1 2026 Earnings Call Transcript
Track CLOV's AI-powered predictions, market trends, and investment insights.
StockTwits Mentions
0
CLOV has been mentioned an estimated 0 times on StockTwits over the last 24 hours.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get StartedThe company remains unprofitable, as indicated by its negative EPS and PE ratio, signaling ongoing earnings pressure. While the loss per share (-0.12) is not extremely large in absolute terms, the lack of positive earnings and profitability keeps the financial profile weak from an equity investor’s standpoint.
The stock’s recent 55.6% gain over the last month and a current price of $3.47 well above the 200-day moving average of $2.54 indicate strong positive momentum. Trading above the long-term moving average typically reflects an uptrend, although the move may be extended and vulnerable to pullbacks depending on shorter-term indicators like RSI (not provided).
Alternative data show modest signs of business and brand activity, with job openings and LinkedIn followers trending up, but social reach on consumer-facing platforms remains small and mixed. These signals point to incremental operational and hiring momentum rather than a strong surge in customer or brand demand.
Clover Health’s stock is showing strong technical momentum, trading well above its 200-day moving average after a sharp recent rally, but the underlying business remains unprofitable and financially fragile. Alternative data suggest gradual operational and brand development rather than a decisive inflection in demand. Overall, the setup appears balanced: technically constructive but fundamentally constrained, resulting in a neutral stance.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
You don't hold CLOV in your mock portfolio yet.

Clover Health Investments, Corp. (CLOV) Q1 2026 Earnings Call Transcript

Clover Health Reports First Quarter 2026 Results

Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026
CLOV StockTwits activity remains notably elevated, with Clover Health logging 2,692 mentions over the past seven days. That level of social chatter places CLOV well above the noise threshold for a sub-$4 stock, suggesting an active retail trading community is closely watching price movements. The conversation is likely shaped by the stock's sharp single-day decline of 4.8%, bringing the share price to $3.98. With nearly 10 million shares traded in the latest session, StockTwits participants appear to be reacting in real time to intraday volatility rather than any clear bullish conviction.
Context matters when interpreting this StockTwits volume. Despite 2,692 mentions in seven days, TrendEdge's AI Score for CLOV sits at just 3 out of 10 — a low reading that signals weak fundamental and technical conditions. The stock's $2.1 billion market cap and elevated daily volume of nearly 10 million shares indicate speculative positioning rather than institutional accumulation. Social mentions spiking alongside a price drop often reflect reactive selling chatter or bottom-fishing attempts, neither of which constitutes a reliable directional signal without additional data layers to support a thesis.
TrendEdge aggregates CLOV StockTwits mentions alongside Reddit activity — currently just 11 mentions in seven days — and cross-references both signals with its proprietary AI Score and trading volume data. This multi-source approach filters out social noise and identifies whether mention spikes are aligned with real price catalysts. When StockTwits volume is high but Reddit engagement and the AI Score remain low, the divergence itself becomes a data point worth monitoring closely.
Unlock comprehensive alternative data signals to make better investment decisions
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
Web Traffic
208,466
Twitter Followers
345
LinkedIn Followers
59,260
Job Postings
56
LinkedIn Employees
740
News Mentions
0
Key Metrics